Denna sida på svenska
Loading profile information...

About me

Following my PhD in innovation management in the cardiac pacemaker industry I have been working in the medical device industry at various management positions in sales, marketing, product management, corporate development, business planning and as a market access consultant. Now working as a senior researcher, lecturer and consultant in the field of medical device innovation with special interest in how innovation is adopted by healthcare. Research questions of interest are: how to define and communicate value of innovation as required in value-based pricing and commercialization of innovation. Experience from market access consulting, market research and forecasting, value-dossier development and involvement in health-economic modelling has given insights on how health economic evidence in driving markets.


Aug 1991- June 1997 PhD-Student, Department of Technology and Social Change, Linköping University, public presentation and dissertation, June 1997

Sept - Dec 1989  Studies in Business Administration, International Marketing, Exportakademie Baden-Württemberg, Reutlingen, Germany

Sept 1988 - Aug 1989 Studies in Economics and Business Administration, Marburg University, Germany

Aug 1986- May 1990 Bachelor of Science, Business Administration and Economics - International Business Programme, Linköping University

Jan-June 1986  Studies in German Language, University of Uppsala

Aug 1980- June 1983 Swedish Gymnasium, Natural Science (Naturvetenskapligt program), Rudbeckianska skolan, Västerås

Research description

The Impact of the Healthcare Innovation System on the Development and Diffusion of Innovations

Successful commercialization of innovations requires a close interactive learning process between users and producers. If customer needs are lost or a lack of capital or of expertise occur the innovation processes stop. A critical phase is the creation of a market for the innovation in collaboration with the healthcare system. This is often hampered by the considerable uncertainty about a new product’s clinical effects and cost effectiveness. It is therefore of interest to ask how well the healthcare system’s related innovation system works? Does it support potentially valuable innovations to diffuse into clinical practice and does it prevent the use of expensive and ineffective methods of care? Do cost effective innovations have a higher success rate within healthcare?

Loading publication list...